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Abstract 
Introduction: Rigid gas permeable lenses have many advantages over soft contact lenses yet due to 
ocular discomfort and associated period of adaptation required with this modality, many practitioners 
neglect to consider this option. Topical anti-inflammatory drugs(NSAIDs), including diclofenac sodium or 
Voltaren, have become popular among practitioners for it's analgesic, anti-inflammatory and anti-puretic 
effects. It has also been demonstrated that Voltaren decreases corneal sensitivity and has an anesthetic 
effect in healthy, unoperated human corneas, and that pretreatment with diclofenac before cataract 
surgery decreases post-operative inflammation. Our proposal is that the use of Voltaren post RGP 
dispense for one week will provide increased comfort, better tolerance and improve adaptability to RGP 
use. 
Sub]ects/Methods: Ten subjects were enrolled, all of whom were new rigid lens wearers and free of 
contraindicating corneal disease. Two randomly selected groups were chosen for either the placebo or 
Voltaren drops. Each subject was evaluated using currently accepted fitting techniques, and at the 
dispense were given a manila envelope containing the masked bottle marked "A" or "B". Each subject filled 
out two questionnaires based on their perception of, and adaptation to, rigid lenses at four intervals: pre-
fitting, after fifteen minutes post-fit, at one week and one month. Each subject was re-evaluated at these 
sessions as well to ensure their lenses were fitting appropriately. 
Results: Statistics were run using unpaired tests for each questionnaire and significance was found, albeit 
in favor of the placebo group, in five categories: Long Term Wear, Comfort, Tearing, Lens Awareness and 
Blinking. 
Discussion: Results from this study indicate that there is no statistical significance in favor of using 
Voltaren versus the placebo. This may have been due to a preexisting bias of those in the placebo group 
even though each subject was randomly assigned, as there was significance found in the Pre-Fit answers 
to the questions of Long Term Wear and Lens Awareness. This factor may have negatively impacted the 
results. Further study needs to be undertaken on this subject, using Voltaren at least three times prior to 
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Abstract 
In trod uction: Rigid gas permeable lenses have many advantages 
over soft contact lenses yet due to ocular discomfort and associated 
period of adaptation required with this modality, many 
practitioners neglect to consider this option. Topical anti- 
inflammatory drugs(NSAIDs), including diclofenac sodium or 
Voltaren, have become popular among practitioners for it's 
analgesic, anti-inflammatory and anti-puretic effects. It has also 
been demonstrated that Voltaren decreases corneal sensitivity and 
has an anesthetic effect in healthy, unoperated human corneas, and 
that pretreatment with diclofenac before cataract surgery decreases 
post-operative inflammation. Our proposal is that the use of 
Voltaren post RGP dispense for one week will provide increased 
comfort, better tolerance and improve adaptability to RGP use. 
Sub]ects/Methods: Ten subjects were enrolled, all of whom were 
new rigid lens wearers and free of contraindicating corneal disease. 
Two randomly selected groups were chosen for either the placebo or 
Voltaren drops. Each subject was evaluated using currently 
accepted fitting techniques, and at the dispense were given a manila 
envelope containing the masked bottle marked "A" or "B". Each 
subject filled out two questionnaires based on their perception of, 
and adaptation to, rigid lenses at four intervals: pre-fitting, after 
fifteen minutes post-fit, at one week and one month. Each subject 
was re-evaluated at these sessions as well to ensure their lenses were 
fitting appropriately. Results: Statistics were run using unpaired t- 
tests for each questionnaire and significance was found, albeit in 
favor of the placebo group, in five categories: Long Term Wear, 
Comfort, Tearing, Lens Awareness and Blinking. Discussion: 
Results from this study indicate that there is no statistical 
significance in favor of using Voltaren versus the placebo. This may 
have been due to a preexisting bias of those in the placebo group 
even though each subject was randomly assigned, as there was 
significance found in the Pre-Fit answers to the questions of Long 
Term Wear and Lens Awareness. This factor may have negatively 
impacted the results. Further study needs to be undertaken on this 
subject, using Voltaren at least three times prior to lens insertion at 
dispense. 
Introduction 
Rigid gas permeable (RGP) contact lenses have many advantages over 
soft contact lenses, yet practitioners often neglect consideration of this 
option due to a number of factors. RGP lenses are more difficult to 
accurately fit than soft lenses, however a more common problem 
encountered by eye-care professionals and their patients is the ocular 
discomfort and associated period of adaptation on initiation of lens wear. 
Due to the smaller diameter and thicker, less flexible composition of RGP 
lenses, lens-wearers often describe ocular foreign body sensation, 
increased blinking frequency, pruritus, lacrimation, movement of the lens, 
photophobia, blurred vision and redness. These symptoms are caused by 
the sensitivity of the cornea and lid margin to the repetitive mechanical 
trauma from blinking against the lens edge. In an effort to reduce these 
symptoms, alterations to the lens architecture have been made with 
limited success.' During the fitting process topical anesthetic drops such as 
proparacaine are often used,' however long-term use is contraindicated 
due to risk of corneal toxicity and the problems with adaptation persist. 
This frequently leads to discontinuation of contact lens wear and 
dissatisfaction of patient and provider alike. 
Topical nonsteroidal anti-inflammatory drugs (NSAIDs) have gained 
widespread popularity among eyecare professionals for their versatility in 
providing relief of ocular discomfort. NSAIDs produce potent analgesic, 
antipyretic and anti-inflammatory  effect^.^ Diclofenac sodium is a member 
of the phenylacetic acid group of NSAIDs. It is thought to act as an 
inhibitor of the cyclooxegenase arm of the arachidonic acid metabolic 
pathway.4 This causes shunting of arachidonic acid to the triglyceride pool 
and reduces its availability for prostacyclin, prostaglandin, thromboxane 
and leukotriene synthesis, which are involved in the inflammatory cascade 
and pain This explains in part both its anti-inflammatory 
effect and its ability to induce corneal anesthesia The complete 
.mechanism of action remalns controversial, and other proposed 
mechanisms include increased levels of beta-endorphins and depressed 
corneal nerve condu~tion.~'~ Side effects are minimal, with a transient 
burning and stinging sensation of varying intensity most commonly 
reported immediately after instillition of drops;419' those with allergy to 
systemic NSAIDs should avoid topical use as well due to risk of 
10, l l  
reaction. 
Studies have shown significant benefits with use of topical diclofenac 
in reducing corneal surface pain following excimer laser corneal refractive 
4,6,11,12 
surgery, traumatic abrasions and removal of corneal rust ring. 
Diclofenac treated patients rarely experience the early peak in pain after 
photorefractive keratectomy, and experience less pain overall. In 
addition, such patients have significantly less post-laser photophobia, 
burning and stinging symptoms. Diclofenac is also effective in treating 
symptoms of allergic conjunctivitis, including episcleritis, hay fever 
conjunctivitis, phlyctenular conjunctivitis, and corneal limbal ulcers." It 
has also been demonstrated that diclofenac decreases corneal sensitivity 
and has an anesthetic effect in healthy, unoperated human corneas, and 
that pretreatment with diclofenac before cataract surgery decreases 
postoperative inflammation.13 With these documented benefits and 
tolerance for diclofenac, we have proposed that use of topical diclofenac 
prior to application of RGP contact lenses and regular use during wear may 
provide increased comfort, better tolerance and improve adaptability to 
RGP use. 
Methods 
Ten subjects (n= 10) were randomly selected to participate in 
this one month study, two female and eight male. All were new rigid 
lens wearers with an average age of 2 4  , an average refractive error 
of: OD -3.18, OS -.2.53, and an average flat K reading of: OD 43.49, 
OS 43.35. All subjects had 20/20 acuity or better and each were 
examined to rule out corneal disease or contraindications. Study 
requirements for patient eligibility were: 
1. All participants must be over 18 years of age, or have 
release signed by parent or guardian, and 
2. All participants must be free of systemic or ocular disease, 
as it relates to standard of care for rigid gas permeable 
contact lens wear, and 
3. All participants must be non-rigid gas permeable lens 
wearers, which includes those who have worn soft contact 
lenses or never worn contact lenses, and 
4. No two subjects can live in the same house, to ensure the 
masked nature of the study. 
Patients who were non-compliant with the prescribed regimen for 
using the assigned drops were removed from the study. As well, any 
subject was free to remove themselves from the study for any 
reason without prejudice. Informed consent was obtained from 
each subject using a consent form approved by the Institutional 
Review Board at Pacific University College of Optometry. 
Paragon HDS CAD lenses were chosen for the study , along 
with (A) 10mL GenTeal and (B) 2.5mL 0.1% Voltaren drops. 
Subjects were randomly assigned a manila envelope containing a 
bottle of drops marked "A" or "B". Both subject and examiner were 
masked as to the contents of the package. The examiner did not see 
the bottles as they were put in the envelopes nor handled the 
envelopes to ensure the masked nature of the study. Subjects were 
asked not to bring their bottles back to the follow-up visits. 
Before the initial lens fitting, each patient filled out two 
questionnaires: (see Appendix A) about their 
perceptlons/expectations and adaptation to rigid contact lenses. 
Adaptation questions pertained to comfort, dryness, itching, 
adaptation and satisfaction and were rated from 0 (very negative) to 
10 ( very positive). Perception questions asked about motivation, 
comfort, sensitivity, blink rate, tearing and overall success. Current 
contact lens fitting techniques were used to fit each patient and the 
criteria for an acceptable fit was: good lid interaction, 3' and 9' bite, 
unimpeded vertical movement and good edge lift. 
Fifteen minutes after the subject's lenses were dispensed, the 
same two questionnaires were filled out regarding 
perception/expectation and adaptation. Afterward each subject 
individually picked out their given manila envelope containing: 
instructions, a statement about rigid gas permeable lenses and their 
benefits (see Appendix B) and a bottle of drops. Each was instructed 
to begin using the drops four times a day (breakfast, lunch, dinner, 
bedtime) for five days. All subjects were provided Boston Original 
Comfort Formula care regimen (Polymer Technology Corporation). 
Follow-up visits were at one week and one month. Lenses 
were re-evaluated to ensure a proper fit and each subject filled out 
the two questionnaires again. 
Results 
Ten out of ten subjects completed the one-month study. In all 
six categories of the "Adaptation" questionnaire no statistically 
significant differences were found between the placebo and Voltaren 
groups, using an unpaired t-test (See Figures 1 2-1 7, Appendix A). 
The average responses were: Overall Comfort: placebo=6.6, 
Voltaren=6.0; Dryness: placebo=6.8, Voltaren=6.4; Itching: 
placebo=6.2, Voltaren=6.7; Adaptation: placebo=7.0, Voltaren=5.6; 
Overall Satisfaction: placebo= 7.3, Voltaren=6.1; Average Wear Time: 
placebo= 10.6, Voltaren=8.3. 
Again using an unpaired t-test for the 'Perception' 
questionnaire, five areas were shown to have statistical significance 
albeit in favor of the placebo group(See Figures 1-1 1, Appendix A). 
The first was "Long Term Wear" (Pre-Fit: p=0.035; Fifteen minutes: 
p=0.020) with average responses of: Pre-Fit, placebo=8.2 vs. 
Voltaren=5.2; Fifteen minutes, placebo=8.2 vs. Voltaren=5.8. The 
question of "Comfort" had significance only at Fifteen 
minutes(p=0.008), with averages of: placebo=7.7 vs. Voltaren=5.0, 
as did "Tearing"(p=0,009) at Fifteen minutes, average of: 
placebo=6.8 vs. Voltaren=4.6. There was a significant difference at 
the Pre-Fit(p=0.005) for " Lens Awareness" with averages of: 
placebo=6.6 vs. Voltaren= 4.0 as well as at Fifteen minutes(p= 
0.001), averages of placebo= 7.2 vs. Voltaren= 3.6. The last 
category with significance was "Blinking" at Fifteen minutes 
(p=0.003), averages of placebo= 6.6 vs. Voltaren= 3.6 and at One 
Week (p=0.010), averages of placebo= 7.2 vs. Voltaren= 2.0. This 
last question had the only statistical significance found at the One 
Week mark 
Discussion 
It is common to have rigid lens patients drop out during the 
initial stages of adaptation, yet all ten of our subjects completed the 
study. This finding is in direct correlation with the results, as it 
accurately reflects how little difference there was between the two 
group's responses. None of the six questions posed on the 
"Adaptation Questionnaire" showed a significant difference between 
the Voltaren and placebo groups in their averages, p=0.533, while 
on the "Perception Questionnaire" four areas showed significant 
differences including: Long Term Wear (Pre-Fit : p=0.035; Fifteen 
minutes: p= 0.020), Comfort (Fifteen minutes: p= 0.008; One week: 
p= 0.057), Tearing (Fifteen minutes: p= 0.009), and Lens Awareness 
(Pre-Fit: p=0.005; Fifteen minutes: p=0.00 1). All four of these areas 
were significantly different in that the placebo group had higher 
average scores than the Voltaren group. 
One factor to consider in light of this is that even initially, on 
the "Perception" questionnaire, there was a statistically significant 
difference on the "Pre-Fit" answers for "Long Term Wear" and "Lens 
Awareness". This may be important in showing that the perceptions 
of those subjects in the placebo group started out at a more positive 
level at than those of the Voltaren group, irregardless of the fact 
that both groups were treated identically in their fitting and 
dispensing visits. Also, each group was given the same statement 
regarding rigid gas permeable lenses and as such should not have 
been subject to any bias. This finding however, may have effected 
the entire study simply because the initial perception of one group 
far outweighed the other, that group being the placebo group, and 
their responses reflected their attitude. To better determine if this 
was the case, a larger sample size in any forthcoming study would 
reduce the likelihood of such bias. 
Initial lens comfort plays a critical role in patients becoming 
successful wearers of rigid lenses. Although the results from this 
study would not seem to indicate that the continued use of anti- 
inflammatory agents post-dispense directly influences patient 
success, the above mentioned variables need to be addressed. 
Subsequent investigations may want to consider beginning Voltaren 
use thirty minutes before lens insertion by instilling one drop in 
each eye at thirty minutes, fifteen m.inutes and finally just prior to 
lens insertion. Voltaren's analgesic effect increases significantly 
only after three or more drops have been instilled, which may have 
been a confounding factor in the current study. Using a larger 
sample size would also prove to be helpful to rule out any 
preconceived bias the subjects might bring into the study. This 
study sought to determine if continued use of anti-inflammatory 
agents after contact lens dispense had any significant effect on 
patient overall satisfaction with their rigid gas permeable lenses. 
The idea that anti-inflammatory agents used post-dispense to 
reduce patient irritation would seem to be a logical off-labeled use 
of the products. Further investigation into this and the analgesic 
effect of these drugs needs to be done, so that another barrier to 
successful patient outcomes with rigid gas permeable lenses is 
overcome. 
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Figures 1 - 1 7 
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Scale 0 - 10 
0 1 2 3 4 5 6 7 8 9 10 
Strongly Neither Strongly 
Disagree I Agree 
Please use the scale above to rate the following statements: - 
1. I am very motivated to wear contact lenses. 
2. I will adapt to RGP's very easily. 
3. I will be a long term wearer of RGP's. 
4. RGP's will be very comfortable. 
5. My eyes are not very sensitive. 
6. My eyes will not tear excessively when wearing RGP's. 
7. I will not be very aware of the lens moving on my eye. 
8. I will not be very aware of blinking excessively. 
9. I feel I will adapt to RGrs in a short amount of time. 
10. My head posture will not change when wearing RGPs. 
11. I expect my RGP fitting experience to be comfortable and pleasant. 
Adaptation Questionnaire 
(To be completed 30 minutes after dispense, after one week and one month) 
Name: Date: 
Please rate the comfort of the contact lenses using the scales below. The scales are numbered 
0-10. Higher numbers indicate greater comfort. Rate the comfort by drawing a short vertical 
line through the scale corresponding to the comfort rating. The vertical line may be placed 
anywhere along the scale. Above the vertical line print R for the right eye, L for the left eye, 
or BOTH if each eye is experiencing identical comfort. 
1. Please rate the overall comfort of the contact lenses. 
- - 
0 1 2 3 4 5 6 7 8 9 1 0  
Severe Moderate Mild Moderate slight No 
Discomfort Discomfort Discomfort Awareness Awareness Awareness 
2. Please rate the sensation of dryness associated with lens wear. 
0 1 2 3 4 5 6 7 8 9 1 0  
Severe Moderate Mild Moderate Slight No 
Discomfort Discomfort Discomfort Awareness Awareness Awareness 
3 .  Please rate the sensation of itching with lens wear. 
0 1 2 3 4 5 6 7 8 9 1 0  
Severe Moderate Mlld Moderate Slight No 
Discomfort Discomfort Discomfort Awareness Awareness Awareness 
4. Please rate your overall adaptation to the lenses. 
Severe Moderate Mlld Moderate Slight No 
Discomfort Discomfort Discomfort Awareness Awareness Awareness 
5 .  Please rate your overall satisfaction with the lenses. 
0 1 2 3 4 5 6 7 8 '9 10 
Severe Moderate Mild Moderate Slight No 
Discomfort Discomfort Discomfort Awareness Awareness Awareness 
6.  Please estimate the average number of hours you have worn the lenses per day. 
7. Please list any other symptoms you are experiencing. 
Please Read 
Rigid gas permeable lenses have the benefits of increased 
oxygen transmission, improved visual clarity, durability, 
and ease of care. It is important, however, that you 
understand there is a difference in adaptation versus soft 
contact lenses. It is not uncommon for you to be aware of 
the lenses when you are first adapting to them only 
because they are small and you are feeling the lids coming 
in contact with the lens when you blink. If you lift up the 
lids the lenses are very comfortable, just as they typically 
will be after your eyes adapt to rigid lens wear. Due to 
this increased awareness, you will be provided with a 
wearing schedule that is important to adhere to in order 
for comfortable wear to be achieved. The process of 
adaptation can take a few days to 2 weeks so keep this in 
mind. 
